Automated pharmacophore hypothesis generator for SILCS-Pharm: ph4gen. [PDF]
Nordquist EB, MacKerell AD.
europepmc +1 more source
Expression of Concern: Discovery of ROCK2 inhibitors through computational screening of ZINC database: Integrating pharmacophore modeling, molecular docking, and MD simulations. [PDF]
PLOS One Editors.
europepmc +1 more source
Computer-Aided Drug Design for Type 2 Diabetes-Related Enzymes: SILCS-Based Fragment Mapping, Pharmacophore Modeling, and Virtual Screening. [PDF]
Mohammadi E, Lemkul JA.
europepmc +1 more source
Identification of Potential SARS-CoV-2 Main Protease (MPro) Inhibitors Through Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Simulation Approaches. [PDF]
Khan MY +5 more
europepmc +1 more source
Discovery of novel acridine based inhibitors of Bruton's tyrosine kinase (BTK) via pharmacophore modeling and machine learning-driven virtual screening followed by molecular dynamic studies. [PDF]
Shahin R +6 more
europepmc +1 more source
Identification of novel PKR inhibitory chemotypes <i>via</i> integrated molecular modelling and machine learning. [PDF]
Shakhatreh G, Taha MO, Daoud S.
europepmc +1 more source
Structure- and Dynamics-Driven Discovery of Small Molecule Inhibitors Targeting a Conserved Pocket near the Fusion Peptide in the Prefusion SARS-CoV‑2 S2 Glycoprotein Subunit. [PDF]
Leusciatti M +5 more
europepmc +1 more source
Ligand-based pharmacophore modeling for the discovery of Na<sub>V</sub>1.7 inhibitors. [PDF]
Piga M +6 more
europepmc +1 more source
In silico pipeline for GSK 3β inhibitor discovery in Alzheimer's disease using pharmacophore screening, docking, ADME filtering, and MD validation. [PDF]
Elkotamy MS +9 more
europepmc +1 more source
Acute Myeloid Leukemia(AML) proteins for in silico drug design using pharmacophore modeling, molecular docking and molecular dynamics simulation. [PDF]
Bosu P +5 more
europepmc +1 more source

